Chinook Therapeutics Inc.

NAS: KDNY

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Chinook Therapeutics Inc.

Market open

KDNY

/zigman2/quotes/207469562/composite

20.59

Change

-0.42 -1.98%

Volume

Volume 122,414

Aug 16, 2022, 10:14 a.m.

Real time quotes

/zigman2/quotes/207469562/composite

Previous close

$ 21.01

$ 20.59

Change

-0.42 -1.98%

Day low

Day high

$20.50

$21.49

Open: 21.21

52 week low

52 week high

$10.48

$21.49

Market cap

$1.29B

Average volume

589,210

P/E ratio

N/A

Rev. per Employee

$393,877

EPS

-1.70

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/kdny

MarketWatch News on KDNY

Chinook Therapeutics started at buy with $30 stock price target at Stifel Nicolaus

7:31 a.m. June 28, 2022

- Tomi Kilgore
Green Plains, Quotient Technology See Activist Action

10:30 p.m. Jan. 21, 2022

- Barron's Online
Chinook Therapeutics initiated at Wedbush at outperform with $28 price target

10:23 a.m. Jan. 6, 2021

- Tonya Garcia
Chinook Therapeutics started at outperform with $32 stock price target at Evercore ISI

8:24 a.m. Nov. 2, 2020

- Tomi Kilgore
Chinook Therapeutics upgraded to outperform from perform at Oppenheimer

8:45 a.m. Oct. 20, 2020

- Tomi Kilgore
Chinook Therapeutics started at outperform with $38 stock price target at SVB Leerink

6:30 a.m. Oct. 7, 2020

- Tomi Kilgore
Aduro Biotech downgraded to perform from outperform at Oppenheimer

9:00 a.m. June 3, 2019

- Tomi Kilgore
Harvard’s Stockpickers Are Beating Yale’s

6:18 p.m. Feb. 13, 2019

- Barron's Online
Aduro Biotech started at outperform with $15 stock price target at Oppenheimer

7:33 a.m. Oct. 31, 2017

- Tomi Kilgore
Why Biotech Looks Like a Good Bet in 2017

3:04 p.m. Feb. 22, 2017

- Barron's Online
Dow, S&P 500 close higher, lifted by surge in mergers

4:16 p.m. Oct. 24, 2016

- Anora Mahmudova
Aduro Biotech stock drops as much as 22% after patient tested positive for listeria

8:44 a.m. Oct. 24, 2016

- Emma Court
Aduro Biotech stock drops 22% after patient tested positive for listeria

8:33 a.m. Oct. 24, 2016

- Emma Court
Aduro Biotech says FDA put trials on partial clinical hold after patient tested positively for listeria

8:33 a.m. Oct. 24, 2016

- Emma Court
Aduro Biotech halted after patient in clinical trial tested positive for listeria

8:31 a.m. Oct. 24, 2016

- Emma Court
Aduro's stock resumes trade, tumbles 35% premarket after disappointing trial results

8:52 a.m. May 16, 2016

- Tomi Kilgore
Aduro Biotech stock halted after cancer drug trial misses primary endpoint

8:50 a.m. May 16, 2016

- Emma R. Court
Aduro Biotech said late-stage pancreatic cancer drug missed primary endpoint

8:39 a.m. May 16, 2016

- Emma R. Court
Aduro Biotech shares halted in premarke trade

8:33 a.m. May 16, 2016

- Ciara Linnane
Aduro Biotech started at outperform with $30 stock price target at Cowen & Co.

10:15 a.m. March 2, 2016

- Tomi Kilgore
Loading more headlines...